glp 1 muscle cramps GLP-1 side effect management: Preventing loss and MSK cost rebound GLP-1 Jabs Linked to Rare

Woo JS, Kim W, Ha SJ, Kim JB, Kim SJ, Kim WS, Seon HJ, Kim KS: Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study

doi: 10.1248/bpb.b14-00505 10 MaoDCaoHShiMWangCCKwongJLiJJXet al

Gina Teel is the director of stakeholder communications for Canada Beef, where she provides timely and effective communication of all Canada Beef initiatives and outcomes to funding partners and industry stakeholders, media, consumers and other external audiences.

Weight loss can alter relationship dynamics, body image perceptions, and self-esteem

Patients should also consider time zone changes when scheduling doses and plan to administer injections at consistent intervals relative to their usual schedule

An estimated 20% of obese patients have minimal or no response to GLP-1s and around 40% stop treatment after 12 months mostly due to shortages, dosage inconvenience3 and costs